The top ophthalmology stories in March included the FDA acceptance of an investigational new drug application for a presbyopia-correcting drop and a look at ophthalmology protocols during the pandemic.
Read the best-performing ophthalmology articles below:
FDA accepts IND for presbyopia drop
The FDA has accepted an investigational new drug application for Brimochol, according to a press release from Visus Therapeutics. Read more.
COVID-19 practice protocols may remain after pandemic ends
The American Academy of Ophthalmology has helped physicians reduce the risk for SARS-CoV-2 transmission in